Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ümit Yavuz Malkan"'
Does Systemic Immune Inflammation Index Predicts Survival In Diffuse Large B Cell Lymphoma Patients?
Autor:
Murat Albayrak, Ahmet Kürşad Güneş, Ümit Yavuz Malkan, Fatma Yılmaz, Hacer Berna Afacan Öztürk, Merih Reis Aras
Publikováno v:
Hitit Medical Journal, Vol 5, Iss 3, Pp 170-174 (2023)
Objective: The systemic immune inflammation index has been considered a novel prognostic biomarker in several malignant tumors. The aim of the current study was to determine the association between the systemic immune inflammation index and prognosis
Externí odkaz:
https://doaj.org/article/43b61cf9e6c64bdd9fe4f329215e5537
Autor:
Hakan Göker, Olgu Erkin Çınar, Haluk Demiroğlu, Ümit Yavuz Malkan, Elifcan Aladağ Karakulak, Yahya Büyükaşık
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 3, Pp 213-215 (2023)
Externí odkaz:
https://doaj.org/article/dcc083bf41e24ef3a3b5eceaa756c4fe
Autor:
Fatma YILMAZ, Murat ALBAYRAK, Abdulkerim YILDIZ, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Ümit Yavuz MALKAN, Pınar AKYOL, Merih REİS ARAS, Buğra SAĞLAM, Mesut TIĞLIOĞLU
Publikováno v:
Ahi Evran Medical Journal, Vol 6, Iss 3, Pp 226-233 (2022)
Purpose: Coronavirus disease 2019 is a viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical and laboratory predictors may provide identification of patients at risk of mortality and guide treatment. This stud
Externí odkaz:
https://doaj.org/article/f82dcc849f63442a9e24b15068368e13
Autor:
Olgu Erkin Çınar, Hakan Göker, Kemal Fidan, Öznur Aydın, Tural Pashayev, Ümit Yavuz Malkan, Mustafa Velet, Yahya Büyükaşık, Salih Aksu, Osman İlhami Özcebe, İbrahim Celalettin Haznedaroğlu, Nilgun Sayınalp, Filiz Vural, Mehmet Turgut, Ali Ünal, Haluk Demiroğlu
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 3, Pp 152-159 (2022)
Objective: Studies comparing the efficacy and safety of prophylactic regimens for central nervous system (CNS) involvement in acute lymphoblastic leukemia (ALL) are scarce in adults. This multicenter retrospective study aimed to compare the efficacy
Externí odkaz:
https://doaj.org/article/199cfb25c23d47808dda621e315aa7a9
Autor:
Ümit Yavuz Malkan, Senem Maral, Fatma Yılmaz, Merih Reis Aras, Buğra Sağlam, Mesut Tığlıoğlu, Hacer Berna Afacan Öztürk, Murat Albayrak, Pınar Tığlıoğlu
Publikováno v:
Sağlık Akademisi Kastamonu, Vol 7, Iss Covid-19 Ek Sayısı, Pp 108-115 (2022)
Introduction Coronavirus disease 2019 (COVID-19) were declared as pandemic by World Health Organization. With this study, we aimed to define our patients who were followed up with malign or benign hematological diagnoses and diagnosed with COVID-19;
Externí odkaz:
https://doaj.org/article/64f1fa33e75d4cfebafd3c5791864f38
Autor:
Rafiye Çiftçiler, Hakan Göker, Haluk Demiroğlu, Salih Aksu, Nilgün Sayınalp, İbrahim C. Haznedaroğlu, Ümit Yavuz Malkan, Yahya Büyükaşık, Osman Özcebe
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 4, Pp 256-262 (2020)
Objective: Multiple myeloma (MM) associated with extramedullary (EM) plasmacytoma has a poor therapeutic response and poor outcomes when treated with conventional chemotherapy. EM plasmacytoma is divided into two groups: the first group comprises tum
Externí odkaz:
https://doaj.org/article/03ddb2e8f8e54a4589b8220efc28125a
Autor:
Rafiye Çiftçiler, İbrahim C. Haznedaroğlu, Nilgün Sayınalp, Osman Özcebe, Salih Aksu, Haluk Demiroğlu, Hakan Göker, Ümit Yavuz Malkan, Yahya Büyükaşık
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 2, Pp 116-120 (2020)
Objective: The prognosis of patients with acute myeloid leukemia (AML) is affected by factors that are both patient- and diseasespecific. The aim of this study is to evaluate the impact of early versus late platelet and neutrophil recovery after indu
Externí odkaz:
https://doaj.org/article/7893300b6f3e4fc39cc5991c21103df8
Autor:
Fatma YILMAZ, Murat ALBAYRAK, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Ümit Yavuz MALKAN, Pınar AKYOL, Merih REİS ARAS, Buğra SAĞLAM, Mesut TIĞLIOĞLU, Abdülkerim YILDIZ
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S19-S20 (2021)
Objective: Coronavirus disease 2019 is an infectious disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical and laboratory predictors may identification of patients at risk of mortality and guide treatment
Externí odkaz:
https://doaj.org/article/6666b030eae34e7dbaa3bbe3e3171e62
Autor:
Olgu Erkin Çınar, Batuhan Erdoğdu, Mine Karadeniz, Sercan Ünal, Ümit Yavuz Malkan, Hakan Göker, İbrahim Celalettin Haznedaroğlu
Publikováno v:
Medicina, Vol 58, Iss 11, p 1575 (2022)
The SARS-CoV-2 spike protein mRNA-based vaccines have prevented countless mortality and morbidity, and have an excellent risk/benefit ratio. However, various adverse events may rarely occur after the BNT162b2 vaccine, like any other medical intervent
Externí odkaz:
https://doaj.org/article/ef5c3aa75b8c48e789413dbf1e92f1da
Autor:
Ümit Yavuz Malkan, Gürsel Güneş, Hakan Göker, İbrahim C. Haznedaroğlu, Kadir Acar, Eylem Eliaçık, Sezgin Etgül, Tuncay Aslan, Seda Balaban, Haluk Demiroğlu, Osman İ. Özcebe, Nilgün Sayınalp, Salih Aksu, Yahya Büyükaşık
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 281-285 (2016)
Objective: Many studies reported an improved prognosis in patients with Burkitt's lymphoma obviating the need of stem cell transplantation. However, prognosis of the advanced disease [i.e. Burkitt's cell leukemia (BCL)] has not been reported with cur
Externí odkaz:
https://doaj.org/article/1c74ba1597b34846a1de542a027b9e28